Herein, for the first time, is reported the presence of CB1R, but not CB2R, in the plasma-derived exosomes from NAFLD patients and their ability to modulate gene and protein expression of both CB receptors and the pathway-related proteins in cultured HepaRG cells. The gene discussed is CNR1; the disease is metabolic dysfunction-associated steatotic liver disease.